Doctors Use CRISPR Technology to Boost Cancer Immunotherapy
THURSDAY, Nov. 10, 2022 (HealthDay News) — Gene editing has for the first time produced modified immune cells finely honed to target and attack cancer cells, researchers say. A team used the gene editing tool CRISPR to alter immune cells drawn from 16 patients who had a variety of solidContinue Reading